Search results
Is Moderna Inc (MRNA) Set to Underperform? Analyzing the Factors
Guru Focus· 2 days agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Why This Small Diagnostics Name Is 'A Stock To Focus On'
Investor's Business Daily· 6 days agoThe March quarter benefited from increases in test volume and average selling price for tests in the...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 6 days ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
FDA delays decision date for Moderna's RSV vaccine - Boston Business Journal
The Business Journals· 6 days agoJust days before its deadline, the U.S. Food and Drug Administration says it's giving itself more...
3 Hot Stocks to Buy That Still Look Undervalued
Morningstar· 3 days agoHere at Morningstar, we talk a lot about the dangers of chasing performance, or buying a stock, ETF, or fund because it’s on a hot streak. Morningstar...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
Motley Fool via Yahoo Finance· 2 days agoThe Motley Fool has positions in and recommends Pfizer. The Motley Fool recommends Moderna. The...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 6 days agoVaccine-maker Novavax announced a $1.2 billion licensing partnership with French pharmaceutical...
Novavax Stock Just Tripled. Is It Too Late to Buy? | The Motley Fool
The Motley Fool· 1 day agoAfter losing more than 90% of its value from a peak back in 2021, Novavax (NVAX -4.30%) stock has...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance· 6 days agoNovavax stock (NVAX) skyrocketed on Friday, nearly doubling on the news French drug and vaccine...
Markets News, May 13, 2024: Stocks End Mixed As Investors Await Key Inflation Data; Dow's Winning...
Investopedia· 3 days agoIncyte's CEO said the repurchase authorization reflects the firm's strong confidence in its...